Literature DB >> 15127085

The Effects of dizocilpine and phencyclidine on prepulse inhibition of the acoustic startle reflex and on prepulse-elicited reactivity in C57BL6 mice.

Benjamin K Yee1, D L Tilly Chang, Joram Feldon.   

Abstract

Prepulse inhibition (PPI) of the acoustic startle response refers to the reduction in startle reaction to a startle-eliciting stimulus when it is shortly preceded by a subthreshold prepulse stimulus. Here, we evaluated the possible effects on prepulse-elicited reactivity by dizocilpine (MK-801) and phencyclidine (PCP) in the PPI of acoustic startle paradigm in C57BL6/J mice. The aim was to ascertain whether these two drugs would affect prepulse-elicited reactivity in a manner similar to apomorphine, which enhances prepulse-elicited reactivity at doses that disrupt PPI. In two dose-response studies, we showed that both drugs exhibited a tendency to attenuate prepulse-elicited reaction at higher doses when PPI was severely disrupted. On the other hand, at lower doses when PPI was marginally disrupted, reaction to the prepulse, if anything, tended to increase. It is concluded that PPI disruption induced by noncompetitive NMDA receptor antagonists can be distinguished from apomorphine-induced PPI disruption by their concomitant effects on prepulse-elicited reactivity. Our data support the suggestion that dopamine receptor agonists and NMDA receptor antagonists disrupt PPI via interference with distinct neural pathways or neuronal systems.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15127085     DOI: 10.1038/sj.npp.1300480

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  32 in total

1.  Modulation of sensorimotor gating in prepulse inhibition by conditional brain glycine transporter 1 deletion in mice.

Authors:  Philipp Singer; Detlev Boison; Hanns Möhler; Joram Feldon; Benjamin K Yee
Journal:  Eur Neuropsychopharmacol       Date:  2010-07-19       Impact factor: 4.600

2.  Prepulse lost and regained: a commentary on "Weak prepulses inhibit but do not elicit startle in rats and humans", Biological Psychiatry 55:98-101.

Authors:  Benjamin K Yee; Joram Feldon
Journal:  Psychopharmacology (Berl)       Date:  2005-01-06       Impact factor: 4.530

3.  Much ado about (almost) nothing: response to 'prepulse lost and regained'.

Authors:  Neal R Swerdlow
Journal:  Psychopharmacology (Berl)       Date:  2005-01-06       Impact factor: 4.530

4.  Withdrawal from repeated amphetamine administration leads to disruption of prepulse inhibition but not to disruption of latent inhibition.

Authors:  D Peleg-Raibstein; E Sydekum; H Russig; J Feldon
Journal:  J Neural Transm (Vienna)       Date:  2005-12-16       Impact factor: 3.575

5.  Validation and pharmacological characterisation of MK-801-induced locomotor hyperactivity in BALB/C mice as an assay for detection of novel antipsychotics.

Authors:  Andrea M Bradford; Kevin M Savage; Declan N C Jones; Mikhail Kalinichev
Journal:  Psychopharmacology (Berl)       Date:  2010-07-31       Impact factor: 4.530

6.  Dissociable effects of the d- and l- enantiomers of govadine on the disruption of prepulse inhibition by MK-801 and apomorphine in male Long-Evans rats.

Authors:  Brittney R Lins; Wendie N Marks; Anthony G Phillips; John G Howland
Journal:  Psychopharmacology (Berl)       Date:  2017-02-08       Impact factor: 4.530

7.  Reversal of scopolamine-induced disruption of prepulse inhibition by clozapine in mice.

Authors:  Philipp Singer; Benjamin K Yee
Journal:  Pharmacol Biochem Behav       Date:  2011-12-21       Impact factor: 3.533

8.  Modulators of the glycine site on NMDA receptors, D-serine and ALX 5407, display similar beneficial effects to clozapine in mouse models of schizophrenia.

Authors:  Tatiana Lipina; Viviane Labrie; Ina Weiner; John Roder
Journal:  Psychopharmacology (Berl)       Date:  2005-03-10       Impact factor: 4.530

9.  NMDA receptor phosphorylation at a site affected in schizophrenia controls synaptic and behavioral plasticity.

Authors:  Bo Li; Nino Devidze; Denis Barengolts; Naseem Prostak; Eleana Sphicas; Alfonso J Apicella; Roberto Malinow; Effat S Emamian
Journal:  J Neurosci       Date:  2009-09-23       Impact factor: 6.167

10.  The alanine-serine-cysteine-1 (Asc-1) transporter controls glycine levels in the brain and is required for glycinergic inhibitory transmission.

Authors:  Hazem Safory; Samah Neame; Yoav Shulman; Salman Zubedat; Inna Radzishevsky; Dina Rosenberg; Hagit Sason; Simone Engelender; Avi Avital; Swen Hülsmann; Jackie Schiller; Herman Wolosker
Journal:  EMBO Rep       Date:  2015-03-09       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.